Common Structural Pattern for Flecainide Binding in Atrial-Selective Kv1.5 and Nav1.5 Channels: A Computational Approach.
Pharmaceutics
Mazola, Yuliet Y; Márquez Montesinos, José C E JCE; Ramírez, David D; Zúñiga, Leandro L; Decher, Niels N; Ravens, Ursula U; Yarov-Yarovoy, Vladimir V; González, Wendy W
Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant.
Cellular And Molecular Life Sciences : Cmls
Al-Moubarak, Ehab E; Shiels, Holly A HA; Zhang, Yihong Y; Du, Chunyun C; Hanington, Oliver O; Harmer, Stephen C SC; Dempsey, Christopher E CE; Hancox, Jules C JC
Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant.
Cellular And Molecular Life Sciences : Cmls
Al-Moubarak, Ehab E; Shiels, Holly A HA; Zhang, Yihong Y; Du, Chunyun C; Hanington, Oliver O; Harmer, Stephen C SC; Dempsey, Christopher E CE; Hancox, Jules C JC
Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1.
Frontiers In Pharmacology
Huang, Mengying M; Liao, Zhenxing Z; Li, Xin X; Yang, Zhen Z; Fan, Xuehui X; Li, Yingrui Y; Zhao, Zhihan Z; Lang, Siegfried S; Cyganek, Lukas L; Zhou, Xiaobo X; Akin, Ibrahim I; Borggrefe, Martin M; El-Battrawy, Ibrahim I
Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
European Journal Of Pharmacology
Zequn, Zheng Z; Yujia, Wu W; Dingding, Qian Q; Jiangfang, Lian L
Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Drug trapping in hERG K+ channels: (not) a matter of drug size?
Medchemcomm
Linder, Tobias T; Bernsteiner, Harald H; Saxena, Priyanka P; Bauer, Florian F; Erker, Thomas T; Timin, Eugen E; Hering, Steffen S; Stary-Weinzinger, Anna A
hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
Journal Of The American Heart Association
Melgari, Dario D; Brack, Kieran E KE; Zhang, Chuan C; Zhang, Yihong Y; El Harchi, Aziza A; Mitcheson, John S JS; Dempsey, Christopher E CE; Ng, G André GA; Hancox, Jules C JC
Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action.
Drug Design, Development And Therapy
Vonderlin, Nadine N; Fischer, Fathima F; Zitron, Edgar E; Seyler, Claudia C; Scherer, Daniel D; Thomas, Dierk D; Katus, Hugo A HA; Scholz, Eberhard P EP
Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
British Journal Of Pharmacology
Jehle, J J; Ficker, E E; Wan, X X; Deschenes, I I; Kisselbach, J J; Wiedmann, F F; Staudacher, I I; Schmidt, C C; Schweizer, P A PA; Becker, R R; Katus, H A HA; Thomas, D D
Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243).
Molecular Pharmacology
Xu, Xulin X; Recanatini, Maurizio M; Roberti, Marinella M; Tseng, Gea-Ny GN
Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome.
British Journal Of Pharmacology
Takemasa, H H; Nagatomo, T T; Abe, H H; Kawakami, K K; Igarashi, T T; Tsurugi, T T; Kabashima, N N; Tamura, M M; Okazaki, M M; Delisle, B P BP; January, C T CT; Otsuji, Y Y
Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.
British Journal Of Pharmacology
Rajamani, S S; Eckhardt, L L LL; Valdivia, C R CR; Klemens, C A CA; Gillman, B M BM; Anderson, C L CL; Holzem, K M KM; Delisle, B P BP; Anson, B D BD; Makielski, J C JC; January, C T CT
Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
British Journal Of Pharmacology
Thomas, Dierk D; Hammerling, Bettina C BC; Wu, Kezhong K; Wimmer, Anna-Britt AB; Ficker, Eckhard K EK; Kirsch, Glenn E GE; Kochan, Mary C MC; Wible, Barbara A BA; Scholz, Eberhard P EP; Zitron, Edgar E; Kathöfer, Sven S; Kreye, Volker A W VA; Katus, Hugo A HA; Schoels, Wolfgang W; Karle, Christoph A CA; Kiehn, Johann J